Business
Crescita Therapeutics(TM) Announces Director Election Results of its Annual General Meeting
Crescita Therapeutics™ Announces Director Election Results of its Annual General Me...
About this update from Crescita Therapeutics, Inc.
[{"type":"text","content":"\n\n\n\nCrescita Therapeutics™ Announces Director Election Results of its Annual General Meeting\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen3{\nBORDER-TOP:black 2pt double; BORDER-RIGHT:black 2pt double; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:black 2pt double; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:black 2pt double; PADDING-RIGHT:0.50em\n}\n.prngen4{\nBORDER-TOP:black 2pt double; BORDER-RIGHT:black 2pt double; BORDER-BOTTOM:black 2pt double; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:black 2pt double; PADDING-RIGHT:0.50em\n}\n.prngen5{\nBORDER-TOP:black 2pt double; BORDER-RIGHT:black 2pt double; BORDER-BOTTOM:black 2pt double; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:black 2pt double; PADDING-RIGHT:0.83em\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n.prnpr6{\nPADDING-RIGHT:0.50em\n}\n.prnsbld{\nBORDER-LEFT:black 2pt double\n}\n.prnpl6{\nPADDING-LEFT:0.50em\n}\n.prnsbbd{\nBORDER-BOTTOM:black 2pt double\n}\n.prnsbrd{\nBORDER-RIGHT:black 2pt double\n}\n.prnbcc{\nBORDER-COLLAPSE: COLLAPSE\n}\n.prnvat{\nVERTICAL-ALIGN: TOP\n}\n.prnsbtd{\nBORDER-TOP:black 2pt double\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, June 13, 2018\n\n\n\nLAVAL, QC, June 13, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (Crescita or the Company), a commercial dermatology company with a portfolio of non-prescription skincare and prescription drug products for the treatment and care of skin conditions, diseases and their symptoms, today announced that all nominees listed in the Management Proxy Circular dated May 8, 2018 were elected as directors of the Company at its 2018 Annual and Special Meeting of Shareholders held at its corporate headquarters in Laval, Québec.\n\n\n \n \n\n \nThe detailed results of the votes by proxy are as follows:\n\n \n\n\n\n\nDirector Nominees\n\n\nNUMBER OF SHARES\n\n\nPERCENTAGE OF VOTES CAST\n\n\n\nFOR\n\n\nWITHHELD\n\n\nFOR\n\n\nWITHHELD\n\n\n\nDaniel N. Chicoine\n\n\n7,296,633\n\n\n723,828\n\n\n91.0%\n\n\n9.0%\n\n\n\nDavid A. Copeland\n\n\n7,311,455\n\n\n709,006\n\n\n91.2%\n\n\n8.8%\n\n\n\nAnthony E. Dobranowski\n\n...